bcl-2: Longevity personified!

Advances in Anatomic Pathology

Volumn 4, Issue 2, 1997, Pages 134-138

  Chetty, Runjan ^a   Dada, Mahomed A ^b   Gatter, Kevin C ^b  

^a UNIVERSITY OF NATAL   (South Africa)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002795362     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Fukuhara S, Rowley JD, Variakojis D, Golomb HM. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res 1979;39:3119-28.
2. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985;229:1390-3.
3. H on chromosome 14 near a transcriptional unit on chromosome 18. Cell 1985;41:899-906.
4. Cleary ML, Smith SD, Sklar J. Cloning and structural analyses of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986;47:19-28.
5. Landanyi M, Wang S. Detection of rearrangements of the BCL 2 major breakpoint region in follicular lymphomas. Correlation of polymerase chain reaction results with Southern blot analysis. Diagn Mol Pathol 1992;1:31-5.
6. Fifth International Workshop on Chromosomes in Leukemia and Lymphoma. Correlation of chromosome abnormalities with histologic and immunologic characteristics in non-Hodgkin's lymphoma and adult T-cell leukemia-lymphoma. Blood 1987;70:1554-64.
7. Pezzella F, Ralfkiaer E, Gatter KC, Mason DY. The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction. Br J Hematol 1990;76:58-64.
8. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M. Multiple recurrent genomic defects in follicular lymphoma. N Engl J Med 1987;316:79-34.
9. Craig RW. The BCL-2 gene family. Semin Cancer Biol 1995;6:35-43.
10. Chen-Levy Z, Nourse J, Cleary ML. The bcl-2 candidate proto-oncogene is a 24 kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol Cell Biol 1989;9:701-10.
11. Krajewski K, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993;53:4701-14.
12. Baer R. Bcl-2 breathes life into embryogenesis. Am J Pathol 1994;145:7-10.
13. Lu Q-L, Abel P, Foster CS, Lalani E-N. bcl-2: Role in epithelial differentiation and oncogenesis. Hum Pathol 1996;27:102-10.
14. Veis-Novack D, Korsmeyer SJ. Bcl-2 protein expression during murine development. Am J Pathol 1994;145:61-73.
15. LeBrun DP, Warnke RA, Cleary ML. Expression of Bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993;142:743-53.
16. McCarthy NJ, Smith CA, Williams GT. Apoptosis in the development of the immune system: growth factors, clonal selection and bcl-2. Cancer Metast Rev 1992;11:157-78.
17. Hockenberry DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-5.
18. Pezzella F, Gatter K. What is the value of bcl-2 protein for histopathologists? Histopathology 1995;26:89-93.
19. Gompel A, Sabourin JC, Martin A, et al. bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 1994;144:1135-42.
20. Sabourin JC, Martin A, Baruch J, et al. bcl-2 expression in normal breast tissue during the normal menstrual cycle. Int J Cancer 1994;59:1-6.
21. Lu Q-L, Elia G, Lucas S, Thomas JA. bcl-2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Cancer 1993;53:29-35.
22. Pezzella F, Turley H, Kuzu I, et al. bcl-2 protein expression in non-small cell lung carcinoma. Immunohistochemical evidence for abnormal expression and correlation with survival. N Engl J Med 1993;329:690-4.
23. Colombel M, Symmans F, Gill S, et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone refractory human prostate cancer. Am J Pathol 1993;143:390-400.
24. McDonnel TJ, Troncoso P, Brisbay SM, et al. Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992;52:6940-4.
25. Strasser A, Harris AW, Bath ML, Cory S. Novel primitive lymphoid tumors induced in transgenic mice by cooperation between bcl-2 and myc. Nature 1990;348:331-3.
26. Chetly R, O'Leary JJ, Biddolph SC, Gatter KC. Immunohistochemical detection of p53 and bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas. J Clin Pathol 1995;48:239-41.
27. Nakamura S, Akazawa K, Kinukawa N, Yao T, Tsuneyoshi M. Inverse correlation between expression of bcl-2 and p53 proteins in primary gastic lymphoma. Hum Pathol 1996;27:225-33.
28. Shen Y, Shenk TE. Viruses and apoptosis. Curr Opin Genet Dev 1995;5:105-11.
29. Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991;65:1107-15.
30. Chetty R, Biddolph SC, Kaklamanis L, et al. bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders. J Pathol (in press).
31. Murray PG, Swinnen LJ, Constandinou CM, et al. BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders. Blood 1996;87:706-11.
32. Khan G, Gupta RK, Coates PJ, Slavin G. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Am J Pathol 1993;143:1270-4.